A Multi-arm, Phase 3, Randomized, Placebo Controlled, Double Blind Clinical Trial to Investigate the Efficacy and Safety of Fostemsavir (BMS-663068/GSK3684934) in Heavily Treatment Experienced Subjects Infected With Multi-drug Resistant HIV-1

ViiV Healthcare

Más información

Fecha de publicación: 2015
Objetivos: Primary Outcome Measures: Mean Change in Logarithm to the Base 10 (log10) HIV-1 Ribonucleic Acid (RNA) From Day 1 at Day 8-Randomized Cohort
Año de Inicio/Término: 2015-2024
Financiamiento/Sponsor: ViiV Healthcare
Rol del Usuario: COLABORADOR(A)
URL: https://clinicaltrials.gov/ct2/show/NCT02362503